|Spatial genomic heterogeneity within localized, multifocal prostate cancer|
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
|Genomic hallmarks of localized, non-indolent prostate cancer|
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
|Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine|
J Bayani, CQ Yao, MA Quintayo, F Yan, S Haider, A D’Costa, CL Brookes, ...
NPJ breast cancer 3 (1), 1-10, 2017
|A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial|
M Spears, N Lyttle, A D'Costa, BE Chen, CQ Yao, PC Boutros, M Burnell, ...
Oncotarget 7 (31), 49099, 2016
|Data Statistics Adviser in Database Management Systems|
A D'Costa, W Gordon, LJ Linta, SC Wang
Proceedings of the 2017 ACM International Conference on Management of Data, 4-6, 2017
|Abstract P2-10-01: Validation that a histone gene signature predicts anthracycline response in early breast cancer|
M Spears, E Kornaga, N Lyttle, L Liao, J Bayani, MA Quintayo, CQ Yao, ...
Cancer Research 78 (4 Supplement), P2-10-01-P2-10-01, 2018
|Abstract P4-07-06: MicroRNAs associated with acquired taxane resistance in a breast cancer cell line model|
KJ Taylor, T Chong, A D'Costa, C Yao, C Gourley, DA Cameron, ...
Cancer Research 77 (4 Supplement), P4-07-06-P4-07-06, 2017
|The mutational landscape of localized gleason 6 and 7 prostate cancer|
ME Fraser, VY Sabelnykova, TN Yamaguchi, A Meng, LE Heisler, J Zhang, ...
Cancer Research 75 (15 Supplement), 2966-2966, 2015